The Notch Signaling Pathway Regulates Basophil Responses During Helminth Infection
Notch 信号通路调节蠕虫感染期间嗜碱性粒细胞的反应
基本信息
- 批准号:10201422
- 负责人:
- 金额:$ 44.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptive TransferAffectBasophilsCD4 Positive T LymphocytesCellsCleaved cellComplexDataDevelopmentDiseaseEpithelial CellsFc ReceptorGATA3 geneGene Expression ProfileGene Expression RegulationGenesHelminthsImmuneIn VitroInfectionInflammationInflammatoryInflammatory ResponseInterleukin-13Interleukin-4IntestinesLigand BindingLigandsLigationLymphocyteMaintenanceMediatingMorbidity - disease rateMusNotch Signaling PathwayNuclear TranslocationParasitesParasitic infectionPathway interactionsPeptide HydrolasesPhenotypePlayPopulationPopulation SizesProcessProductionRoleShapesSignal TransductionSourceTestingTh2 CellsTimeTranscriptional ActivationTrichurisbasecytokineexperimental studygastrointestinalgranulocytehelminth infectionin vitro Assayin vivoloss of functionneutralizing antibodynotch proteinnovel therapeuticsprogenitorreceptor bindingresponsetargeted treatment
项目摘要
PROJECT SUMMARY
Intestinal helminth parasites infect millions of people worldwide and cause significant morbidity. Host-
protective type 2 inflammation is characterized by activation of innate immune cells, polarization of naïve CD4+
T cells to T helper type 2 cells, anti-helminth epithelial cell responses, and worm expulsion. Recent studies
have revealed that basophils, rare innate granulocytes, promote type 2 inflammation and worm expulsion, but
the pathways that control basophil effector function following helminth infection remain incompletely defined.
However, the Notch signaling pathway stands out as a key candidate that could regulate basophil responses in
this context. Ligand binding to a Notch receptor leads to nuclear translocation of the Notch intracellular
domain, which can promote transcriptional activation of canonical type 2 inflammation-associated target genes
and the development of type 2 inflammatory responses. However, how Notch shapes basophil responses that
regulate intestinal type 2 inflammation and helminth expulsion in vivo is unknown. To address this, in
preliminary studies, we show for the first time that murine basophils expressed Notch 2 following infection with
the intestinal helminth parasite Trichuris muris. Using mice in which Notch signaling is genetically blocked
solely in basophils, we demonstrate that while Notch signaling was not required to maintain the basophil
population in the steady state, it does contribute to optimal basophil population expansion and helminth
clearance following T. muris infection. Finally, we show that Notch signaling regulates cytokine-elicited
basophil activation in vitro. Collectively, these data led us to hypothesize that during intestinal helminth
parasite infection, basophils upregulate Notch and respond to Notch ligands, mediating optimal basophil
population expansion and effector function and efficient helminth expulsion. To test this, we propose three
specific aims. Studies in Aim 1 will test how the Notch signaling pathway regulates basophil population
expansion and differentiation during type 2 inflammation, employing in vitro assays and in vivo approaches
during T. muris infection. Studies in Aim 2 will test how Notch signaling promotes basophil effector function
and contributions to type 2 inflammation in vivo using adoptive transfer studies and infection with T. muris, with
some studies focusing on the role of Notch 2 in this process. Studies in Aim 3 will test how Notch ligands or
helminth proteases could activate Notch signaling in basophils to promote effector function and type 2
inflammation, using in vivo experiments during T. muris infection and in vitro assays. These studies will dissect
how Notch signaling regulates basophil responses that drive type 2 inflammation in the intestine following
helminth parasite infection. Our results will expand our understanding of intestinal type 2 inflammation and
inform the development and use of therapies that target Notch to treat type 2 inflammatory diseases.
项目摘要
肠道蠕虫寄生虫感染全世界数百万人并导致显著的发病率。主持人-
保护性2型炎症的特征在于先天免疫细胞的激活,幼稚CD 4+细胞的极化,
T细胞转化为2型辅助性T细胞,抗蠕虫上皮细胞反应和蠕虫排出。最近的研究
已经发现嗜碱性粒细胞,罕见的先天性粒细胞,促进2型炎症和蠕虫驱逐,但
蠕虫感染后控制嗜碱性粒细胞效应子功能的途径仍不完全确定。
然而,Notch信号通路作为一个关键的候选者,可以调节嗜碱性粒细胞的反应,
这个背景。配体与Notch受体结合导致Notch细胞内的核转位
结构域,其可以促进典型的2型炎症相关靶基因的转录激活
以及2型炎症反应的发展。然而,Notch如何塑造嗜碱性粒细胞的反应,
体内调节肠2型炎症和蠕虫排出是未知的。为了解决这个问题,在
初步研究,我们首次表明,小鼠嗜碱性粒细胞表达Notch 2感染后,
肠道蠕虫寄生虫鼠鞭虫使用Notch信号被基因阻断的小鼠
仅在嗜碱性粒细胞中,我们证明,虽然Notch信号传导不需要维持嗜碱性粒细胞
在稳定状态下,它确实有助于嗜碱性粒细胞的最佳种群扩张和蠕虫
T.之后的间隙。小鼠感染。最后,我们发现Notch信号调节了精氨酸引起的
体外嗜碱性粒细胞活化。总的来说,这些数据使我们假设,在肠道蠕虫
寄生虫感染,嗜碱性粒细胞上调Notch并对Notch配体产生应答,介导最佳嗜碱性粒细胞
种群扩张和效应器功能以及有效的蠕虫驱逐。为了验证这一点,我们提出了三个
明确的目标。目标1中的研究将测试Notch信号通路如何调节嗜碱性粒细胞群体
2型炎症过程中的扩增和分化,采用体外测定和体内方法
在T.小鼠感染。目标2中的研究将测试Notch信号传导如何促进嗜碱性粒细胞效应子功能
以及使用过继转移研究和T.穆里斯,与
一些研究集中在Notch 2在这一过程中的作用。目标3中的研究将测试Notch配体或
蠕虫蛋白酶可以激活嗜碱性粒细胞中的Notch信号,以促进效应功能和2型
炎症,在T.小鼠感染和体外测定。这些研究将剖析
Notch信号如何调节嗜碱性粒细胞反应,驱动肠道中的2型炎症,
蠕虫寄生虫感染我们的研究结果将扩大我们对肠道2型炎症的理解,
为靶向Notch治疗2型炎性疾病的疗法的开发和使用提供信息。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Helminths make themselves at home.
- DOI:10.1084/jem.20212207
- 发表时间:2022-01-03
- 期刊:
- 影响因子:0
- 作者:Tait Wojno ED
- 通讯作者:Tait Wojno ED
Immune System Investigation Using Parasitic Helminths.
- DOI:10.1146/annurev-immunol-093019-122827
- 发表时间:2021-04-26
- 期刊:
- 影响因子:29.7
- 作者:Douglas B;Oyesola O;Cooper MM;Posey A;Tait Wojno E;Giacomin PR;Herbert DR
- 通讯作者:Herbert DR
The role of rare innate immune cells in Type 2 immune activation against parasitic helminths.
- DOI:10.1017/s0031182017000488
- 发表时间:2017-09
- 期刊:
- 影响因子:2.4
- 作者:Webb LM;Tait Wojno ED
- 通讯作者:Tait Wojno ED
Plasmacytoid Dendritic Cells Facilitate Th Cell Cytokine Responses throughout Schistosoma mansoni Infection.
- DOI:10.4049/immunohorizons.2100071
- 发表时间:2021-08-30
- 期刊:
- 影响因子:0
- 作者:Webb LM;Phythian-Adams AT;Costain AH;Brown SL;Lundie RJ;Forde-Thomas J;Cook PC;Jackson-Jones LH;Marley AK;Smits HH;Hoffmann KF;Tait Wojno ED;MacDonald AS
- 通讯作者:MacDonald AS
Cytokines and beyond: Regulation of innate immune responses during helminth infection.
- DOI:10.1016/j.cyto.2018.08.021
- 发表时间:2020-09
- 期刊:
- 影响因子:3.8
- 作者:Oyesola OO;Früh SP;Webb LM;Tait Wojno ED
- 通讯作者:Tait Wojno ED
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elia D Tait Wojno其他文献
Epithelial-immune interactions govern type 2 immunity at barrier surfaces
上皮-免疫相互作用在屏障表面调控 2 型免疫。
- DOI:
10.1016/j.coi.2024.102501 - 发表时间:
2024-12-01 - 期刊:
- 影响因子:5.800
- 作者:
Alejandra Lopez Espinoza;Tighe Christopher;Elia D Tait Wojno - 通讯作者:
Elia D Tait Wojno
Elia D Tait Wojno的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elia D Tait Wojno', 18)}}的其他基金
Prostaglandin D2 and its receptor CRTH2 regulate intestinal inflammation and homeostasis
前列腺素 D2 及其受体 CRTH2 调节肠道炎症和体内平衡
- 批准号:
10733671 - 财政年份:2023
- 资助金额:
$ 44.13万 - 项目类别:
The Notch Signaling Pathway Regulates Basophil Responses During Helminth Infection
Notch 信号通路调节蠕虫感染期间嗜碱性粒细胞的反应
- 批准号:
9986356 - 财政年份:2019
- 资助金额:
$ 44.13万 - 项目类别:
Role of the prostaglandin D2 receptor CRTH2 in helminth-induced type 2 inflammation in the intestine
前列腺素 D2 受体 CRTH2 在蠕虫引起的肠道 2 型炎症中的作用
- 批准号:
9986377 - 财政年份:2019
- 资助金额:
$ 44.13万 - 项目类别:
Role of the prostaglandin D2 receptor CRTH2 in helminth-induced type 2 inflammation in the intestine
前列腺素 D2 受体 CRTH2 在蠕虫引起的肠道 2 型炎症中的作用
- 批准号:
10228717 - 财政年份:2019
- 资助金额:
$ 44.13万 - 项目类别:
Cytokine regulation of human basophil responses
人类嗜碱性粒细胞反应的细胞因子调节
- 批准号:
8255795 - 财政年份:2012
- 资助金额:
$ 44.13万 - 项目类别:
Cytokine regulation of human basophil responses
人类嗜碱性粒细胞反应的细胞因子调节
- 批准号:
8433040 - 财政年份:2012
- 资助金额:
$ 44.13万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 44.13万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 44.13万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 44.13万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 44.13万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 44.13万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 44.13万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 44.13万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 44.13万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 44.13万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 44.13万 - 项目类别: